Background & Aims\ud \ud Patients with non-alcoholic steatohepatitis (NASH) have increased mortality, including from infections. We, therefore, tested in a rodent model of steatohepatitis whether the hepatic acute phase response is intact.\ud \ud Methods\ud \ud Steatohepatitis was induced in rats by feeding a high-fat, high-cholesterol diet for 4 (early) and 16 weeks (advanced NASH). 2 h after low-dose LPS (0.5 mg/kg i.p.), we measured the serum concentrations of tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6). We also measured liver mRNA's and the serum concentrations of acute phase proteins 24 h after LPS.\ud \ud Results\ud \ud Non-alcoholic steatohepatitis in itself increased the liver mRNA levels of TNF-α and IL-6 and also the...
The pathogenesis of nonalcoholic steatohepatitis (NASH) and inflammasome activation involves sequent...
BACKGROUND/AIMS: Pathogenesis of non-alcoholic steatohepatitis (NASH) remains poorly understood. Cyt...
Toll-like receptors (TLR) recognize pathogen-derived molecules and induce downstream activation of i...
Background & Aims Patients with non-alcoholic steatohepatitis (NASH) have increased mortality, in...
Background & Aims Patients with non-alcoholic steatohepatitis (NASH) have increased mortality, in...
Background & AimsPatients with non-alcoholic steatohepatitis (NASH) have increased mortality, includ...
BACKGROUND: Nonalcoholic steatohepatitis (NASH) develops in the absence of chronic and excessive alc...
BACKGROUND: Nonalcoholic steatohepatitis (NASH) develops in the absence of chronic and excessive alc...
The nature of the chronic inflammatory component that drives the development of non-alcoholic steato...
The nature of the chronic inflammatory component that drives the development of non-alcoholic steato...
The nature of the chronic inflammatory component that drives the development of non-alcoholic steato...
The nature of the chronic inflammatory component that drives the development of non-alcoholic steato...
The nature of the chronic inflammatory component that drives the development of non-alcoholic steato...
Copyright © 2009 JCBNSummary Nonalcoholic steatohepatitis (NASH) can develop into end-stage disease ...
BACKGROUND: Nonalcoholic steatohepatitis (NASH) develops in the absence of chronic and excessive alc...
The pathogenesis of nonalcoholic steatohepatitis (NASH) and inflammasome activation involves sequent...
BACKGROUND/AIMS: Pathogenesis of non-alcoholic steatohepatitis (NASH) remains poorly understood. Cyt...
Toll-like receptors (TLR) recognize pathogen-derived molecules and induce downstream activation of i...
Background & Aims Patients with non-alcoholic steatohepatitis (NASH) have increased mortality, in...
Background & Aims Patients with non-alcoholic steatohepatitis (NASH) have increased mortality, in...
Background & AimsPatients with non-alcoholic steatohepatitis (NASH) have increased mortality, includ...
BACKGROUND: Nonalcoholic steatohepatitis (NASH) develops in the absence of chronic and excessive alc...
BACKGROUND: Nonalcoholic steatohepatitis (NASH) develops in the absence of chronic and excessive alc...
The nature of the chronic inflammatory component that drives the development of non-alcoholic steato...
The nature of the chronic inflammatory component that drives the development of non-alcoholic steato...
The nature of the chronic inflammatory component that drives the development of non-alcoholic steato...
The nature of the chronic inflammatory component that drives the development of non-alcoholic steato...
The nature of the chronic inflammatory component that drives the development of non-alcoholic steato...
Copyright © 2009 JCBNSummary Nonalcoholic steatohepatitis (NASH) can develop into end-stage disease ...
BACKGROUND: Nonalcoholic steatohepatitis (NASH) develops in the absence of chronic and excessive alc...
The pathogenesis of nonalcoholic steatohepatitis (NASH) and inflammasome activation involves sequent...
BACKGROUND/AIMS: Pathogenesis of non-alcoholic steatohepatitis (NASH) remains poorly understood. Cyt...
Toll-like receptors (TLR) recognize pathogen-derived molecules and induce downstream activation of i...